ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1742

A Novel Murine Model of B Cell-Mediated Proteinuria Suggests Cytokines Mediate Podocyte Injury

Alfred Kim1 and Andrey S. Shaw2, 1IM/Div of Rheumatology, Washington Univ School of Med, St. Louis, MO, 2Pathology & Immunology/HHMI, Washington University School of Medicine, Saint Louis, MO

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: B cells, cytokines and proteinuria

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

B cell depletion therapies have been efficacious in several glomerulopathies. The contributions of B cells to proteinuria and foot process effacement remain unknown. The development of a murine model of B-cell induced proteinuria would enhance our understanding of immune-based glomerular diseases.

Methods:

The B cell model antigen model hen egg lysozyme (HEL) was biotinylated and complexed to avidin. Following intravenous (IV) injection in mice, purified naïve HEL-specific B cells were adoptively transferred and proteinuria assessed using PAGE. Kidneys were processed for immunofluorescence (IF), H&E and PAS staining, and scanning electron microscopy (SEM). Cultured podocyte membrane ruffling was assessed with DIC videomicroscopy.

Results:

HEL embedded within the glomerular basement membrane (GBM) following IV injection. Proteinuria occurred after the transfer of HEL-specific B cells and was associated with foot process effacement. No antibody or complement deposition was observed in the GBM. 2-photon microscopy of live mice demonstrated that HEL-specific B cells arrested trafficking within glomeruli in the presence of HEL.

The rapid kinetics of proteinuria induction suggested cytokines secreted by activated intraglomerular B cells may be responsible. We hypothesize that activation of the small Rho GTPase Rac is important in podocyte injury by virtue of its ability to regulate the actin cytoskeleton. Using murine cultured podocytes, we measured membrane ruffling in the presence of cytokines as a surrogate for Rac activation. IL-4 significantly increased cultured podocyte membrane ruffling and induced foot process retractions on ex vivo fragments of renal cortex. Hydrodynamic DNA immunization of wild-type 129 mice with plasmid encoding IL-4 lead to proteinuria.

Conclusion:

We have developed a novel model of B cell-induced proteinuria with foot process effacement. Furthermore, these data demonstrate that cytokines can induce alterations in foot process morphology, leading to proteinuria. This has important implications in therapies preserving podocyte function in glomerular disease.


Disclosure:

A. Kim,
None;

A. S. Shaw,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-murine-model-of-b-cell-mediated-proteinuria-suggests-cytokines-mediate-podocyte-injury/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology